DEF: Brighthouse Financial Sets June 2, 2026 Annual Meeting Date

Sentiment:

Proxy Statement


Brighthouse Financial announces its 2026 Annual Meeting of Stockholders, scheduled for June 2, 2026, to address director elections, auditor ratification, and executive compensation, amidst ongoing merger discussions.

Delay expectedThe merger is subject to customary closing conditions, including receipt of insurance regulatory approvals, which could impact the expected closing timeline in 2026.

Summary

  • Brighthouse Financial has scheduled its 2026 Annual Meeting of Stockholders for June 2, 2026, to be held virtually.
  • Key proposals include the election of nine directors, ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and an advisory vote on executive compensation.
  • The meeting will be held solely by remote communication via the internet.
  • Stockholders of record as of April 6, 2026, are entitled to vote.
  • The company is proceeding with its merger with an affiliate of Aquarian Capital LLC, valued at $70.00 per common share in cash, expected to close in 2026.
  • The merger agreement was adopted by stockholders on February 12, 2026.
  • In 2025, the company achieved a combined risk-based capital ratio of 456%, exceeded annuity and life insurance sales targets, and managed corporate expenses effectively.
  • The Board of Directors recommends voting FOR the election of director nominees and FOR Proposals 2 and 3.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to strong operational performance in 2025, significant shareholder returns via buybacks, and a favorable merger agreement, despite the inherent uncertainties of regulatory approvals for the transaction.

Positives

  • The company achieved a strong year-end combined risk-based capital ratio of 456% in 2025, exceeding its target range.
  • Annuity sales increased by 3% to $10.3 billion in 2025, with Shield Level Annuities sales reaching a record high, up 4% from 2024.
  • Life insurance sales reached a record $143 million in 2025, a 19% increase over 2024.
  • Corporate expenses in 2025 were better than planned, excluding acquisition-related costs.
  • The company repurchased $102 million of its common stock in 2025, reducing shares outstanding by over 52% since August 2018.
  • The 2025 Say-on-Pay proposal received strong stockholder support with 93.1% approval.
  • The Board of Directors is composed of experienced individuals with diverse skills relevant to the company's strategy and risk oversight.
  • The company has a robust corporate governance framework, including an independent Chairman and a majority independent Board.

Negatives

  • Corporate expenses in 2025 included $31.6 million in costs related to the pending acquisition.
  • The company agreed not to repurchase its stock following the expiration of its Rule 10b5-1 plan in May 2025, due to the Merger Agreement.
  • The merger is subject to customary closing conditions, including receipt of insurance regulatory approvals, which could cause delays.

Risks

  • The pending merger is subject to customary closing conditions, including receipt of insurance regulatory approvals, which could impact the closing timeline.
  • The company faces risks and uncertainties that could cause actual results to differ materially from forward-looking statements, as detailed in its SEC filings.
  • The company's financial performance and strategic objectives are subject to various market conditions, competitive landscape, and regulatory developments.

Future Outlook

The company anticipates the closing of the merger with Aquarian Capital LLC in 2026, subject to regulatory approvals. In the interim, the Board is focused on supporting the merger process while maintaining oversight of ongoing operations and risk management. The 2026 compensation program remains largely consistent with 2025, with LTI awards for 2026 consisting entirely of RSUs in anticipation of the merger.

Management Comments

  • "As a Board, our focus has always been to help management grow the long-term value of the Company for our stockholders, and we are excited for this new chapter for the Company, as it continues its mission to help people achieve financial security."
  • "We are proud that, after a comprehensive and rigorous process, aided by outside legal and financial advisors, the Board unanimously approved the Company's entry into the Merger Agreement."
  • "While we were engaged in the exploration of a sale of the Company, we remained diligent in the oversight of the Company's strategy."
  • "As we prepare for the anticipated closing of the Merger in 2026, the Board expresses its sincere appreciation for your investment, support, and engagement over the years."

Industry Context

StockSavvy.ai notes that Brighthouse Financial's proxy statement reflects a company navigating a significant strategic transition with a pending acquisition, while continuing to report on its operational performance and governance practices. The focus on capital strength, sales growth in annuities and life insurance, and expense management aligns with key industry trends in the life insurance and annuity sector.

Comparison to Industry Standards

  • Brighthouse Financial's combined risk-based capital (RBC) ratio of 456% in 2025 is noted as being above its target range of 400% to 450%, indicating strong capital adequacy compared to industry expectations for solvency.
  • The company's annuity sales of $10.3 billion represent a 3% increase over 2024, with Shield Level Annuities sales up 4%. This performance in the registered index-linked annuity (RILA) market positions Brighthouse as a leader in this growing segment, often outperforming broader annuity market growth rates.
  • Life insurance sales of $143 million, a 19% increase, demonstrate strong performance in a competitive market. This growth rate is notable when compared to industry averages which have seen more modest gains in traditional life insurance products.
  • The executive compensation structure, with a significant portion of Target Total Direct Compensation (TDC) in variable, at-risk elements (STI and LTI), aligns with best practices advocated by investor groups like the Investor Stewardship Group for U.S. listed companies, emphasizing pay-for-performance.
  • The company's commitment to corporate governance, including an independent board majority and an independent Chairman, aligns with recommendations from governance advocates and institutional investors seeking robust oversight.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board is composed of nine Directors, with eight of them being independent. The Board has a mix of tenures and diverse skills relevant to the company's strategy and risk oversight.OngoingEnhances independent oversight and strategic guidance.
Board Leadership StructureThe Board is led by an independent Chairman, C. Edward Chaplin, with the CEO serving as a Director. This structure is intended to promote independent oversight.OngoingSeparates oversight and executive management roles, fostering accountability.
Director Nomination ProcessThe Nominating and Corporate Governance Committee leads the search for Director candidates based on skills, experience, and background, utilizing professional search firms.OngoingEnsures a qualified and diverse Board composition aligned with company needs.
Overboarding PolicyA policy limits Directors to serving on no more than three other public company boards, ensuring sufficient time commitment.OngoingPromotes active engagement and effective oversight from Directors.
Mandatory Retirement AgeDirectors may not stand for reelection or be appointed after reaching the age of 72.OngoingFacilitates Board refreshment while retaining experienced members.
Executive Compensation PhilosophyThe compensation program is rooted in a pay-for-performance philosophy, aligning executive pay with company and individual performance and stockholder interests.OngoingIncentivizes executives to drive long-term stockholder value and achieve strategic goals.
Related Person Transaction Approval PolicyTransactions involving related persons require review and approval by the Nominating and Corporate Governance Committee to ensure they are not inconsistent with the company's best interests.OngoingEnsures fairness and transparency in transactions with related parties.

Related Party Transactions

  • Transactions with beneficial owners of more than 5% of outstanding common stock, such as BlackRock, Inc., are conducted at arm's length in the ordinary course of business, including investment management agreements and use of portfolio management software.
  • Brighthouse Financial was selected by BlackRock as an insurer to help deliver its LifePath Paycheck solution, with an account value of $569 million as of December 31, 2025. This transaction was approved by the Nominating and Corporate Governance Committee.

Stakeholder Impact

  • Shareholders: The pending merger offers shareholders $70.00 per common share in cash, representing a significant return. The company's strong capital position and sales performance in 2025 also support ongoing shareholder value.
  • Employees: The company emphasizes human capital management, talent development, and fostering an inclusive culture. Executive compensation is designed to align with long-term company success.
  • Customers: The company's mission is to help people achieve financial security through annuities and life insurance products designed for simplicity, transparency, and value.
  • Distribution Partners: The company aims to provide value through a diverse network of distribution partners and build strategic relationships.

Next Steps

  • Attend the 2026 Annual Meeting of Stockholders on June 2, 2026.
  • Vote on the election of directors, ratification of the independent auditor, and advisory approval of executive compensation.
  • Await the closing of the merger with Aquarian Capital LLC, expected in 2026, subject to regulatory approvals.

Key Dates

DateDescription
2025-11-06Entry into the Agreement and Plan of Merger (Merger Agreement).
2025-12-31Fiscal year end for which financial metrics are reported.
2026-01-07Filing date of the company's definitive proxy statement related to the Merger.
2026-02-12Special meeting where Brighthouse Financial stockholders adopted the Merger Agreement.
2026-03-01Grant date for 2025 Long-Term Incentive Awards (RSUs and PSUs).
2026-04-06Record Date for determining stockholders entitled to vote at the Annual Meeting.
2026-04-14Date proxy materials were first made available, sent, or given to stockholders.
2026-05-29Deadline for plan participants to submit voting instructions to the Trustee.
2026-06-01Deadline to submit proxy votes via internet or telephone.
2026-06-02Date and time of the 2026 Annual Meeting of Stockholders (8:00 a.m. Eastern Time).
2026Expected closing year for the Merger.
2027-06-02Term end date for elected Directors.

Recommendation

hold

The filing indicates a pending acquisition at a fixed price per share, which limits upside potential for shareholders. While the company reported strong operational results in 2025, the immediate future is largely defined by the closing of the merger. Therefore, a 'hold' recommendation is appropriate, allowing investors to await the completion of the transaction and receive the agreed-upon cash consideration.

Keywords

Brighthouse Financial, Proxy Statement, Annual Meeting, Merger, Aquarian Capital, Executive Compensation, Director Election, Auditor Ratification, SEC Filing, DEF 14A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.